Skip to main content
. 2018 Mar 22;36(3):230–238. doi: 10.5534/wjmh.170004

Table 1. Baseline characteristics of patients.

Characteristic TFGL 400 (n=44) Placebo (n=44) p-value
Age (y) 59.2±7.7 57.0±8.4 0.214
Height (cm) 168.2±5.9 170.1±4.7 0.092
Body weight (kg) 71.1±10.3 70.2±7.4 0.648
BMI (kg/m2) 25.1±3.2 24.3±2.2 0.146
AMS 38.3±11.3 37.9±8.9 0.868
IIEF 41.3±19.2 40.7±17.9 0.877
ADAM questionnaire positive rate 44 (100) 44 (100) -
PSS-10 16.9±4.2 17.1±17.9 0.934
Serum total testosterone (ng/mL) 4.3±1.4 4.4±1.4 0.895
Serum free testosterone (pg/mL) 7.7±2.1 7.7±2.2 0.930
Serum total cholesterol (mg/dL) 182.3±26.2 183.0±26.2 0.900
Serum HDL-C (mg/dL) 44.1±6.1 44.0±6.2 0.918
Serum LDL-C (mg/dL) 115.0±26.0 117.7±21.3 0.589
Serum triglyceride (mg/dL) 219.0±55.3 223.4±58.9 0.717

Values are presented as mean±standard deviation or number (%). p-value indicates the independence sample t-test.

TFGL: Trigonella foenum-graecum seed and Lespedeza cuneate, BMI: body mass index, AMS: Aging Males' Symptoms scale, IIEF: International Index of Erectile Function, ADAM: Androgen Deficiency in the Aging Males, PSS-10: perceived stress scale-10, HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol.